RxDoctor Payments Data

Enbal Baram

Physician Assistant · Babylon, NYNPI 1285834820

Payments from drug & device makers

$1,501in general payments, 2019–2025

Across 71 payments — averaging $21.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exact Sciences$262
  • Abbott$252
  • Bayer$168
  • Medtronic$95
  • Baxter Healthcare$88
  • Novo Nordisk$75
  • plus $561 from 16 others

What the payments were for

  • Food & beverage$1,41394%
  • Other$886%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,501 in reported general payments places this provider in the 80th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide114$167,942
MounjaroTirzepatide62$84,120
EliquisApixaban47$64,967
XareltoRivaroxaban47$59,646
JardianceEmpagliflozin35$56,513
FarxigaDapagliflozin Propanediol33$46,683
Xigduo XrDapaglifloz Propaned/Metformin22$37,420
Tresiba Flextouch U-200Insulin Degludec15$35,158
RybelsusSemaglutide18$31,338
JanumetSitagliptin Phos/Metformin Hcl24$29,480
JanuviaSitagliptin Phosphate19$19,045
MyrbetriqMirabegron20$17,083
TrulicityDulaglutide13$15,705
NamzaricMemantine Hcl/Donepezil Hcl13$13,159
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$12,406

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$75$199,280132 claims
Lilly USA, LLCMounjaro, Trulicity$60$99,82575 claims
PfizerEliquis$35$64,96747 claims
Johnson & JohnsonXarelto$18$59,64647 claims
AstraZenecaFarxiga, Breztri Aerosphere$27$59,08946 claims
MerckJanumet, Januvia$63$48,52543 claims
AbbVieNamzaric, Synthroid$40$17,45482 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Babylon

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →